Tvardi Therapeutics, Inc. (TVRD)
Nasdaq: TVRD · CIK 0001346830 · United States
Every official Tvardi Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TVRD filings
Tvardi Therapeutics, Inc. documents
- Tvardi Therapeutics, Inc. 10-K 2026TVRD 10-K 2026: annual report for fiscal 2026
- Tvardi Therapeutics, Inc. 10-K 2025TVRD 10-K 2025: annual report for fiscal 2025
- Tvardi Therapeutics, Inc. 10-K 2024TVRD 10-K 2024: annual report for fiscal 2024
- Tvardi Therapeutics, Inc. 10-K 2023TVRD 10-K 2023: annual report for fiscal 2023
- Tvardi Therapeutics, Inc. 10-K 2022TVRD 10-K 2022: annual report for fiscal 2022
- Tvardi Therapeutics, Inc. 10-Q 2026TVRD 10-Q 2026: quarterly report for fiscal 2026
- Tvardi Therapeutics, Inc. 10-Q 2025TVRD 10-Q 2025: quarterly report for fiscal 2025
- Tvardi Therapeutics, Inc. 10-Q 2024TVRD 10-Q 2024: quarterly report for fiscal 2024
- Tvardi Therapeutics, Inc. 10-Q 2023TVRD 10-Q 2023: quarterly report for fiscal 2023
- Tvardi Therapeutics, Inc. 10-Q 2022TVRD 10-Q 2022: quarterly report for fiscal 2022
- Tvardi Therapeutics, Inc. 8-K 2026TVRD 8-K 2026: current report for fiscal 2026
- Tvardi Therapeutics, Inc. 8-K 2025TVRD 8-K 2025: current report for fiscal 2025
- Tvardi Therapeutics, Inc. 8-K 2024TVRD 8-K 2024: current report for fiscal 2024
- Tvardi Therapeutics, Inc. 8-K 2023TVRD 8-K 2023: current report for fiscal 2023
- Tvardi Therapeutics, Inc. 8-K 2022TVRD 8-K 2022: current report for fiscal 2022
- Tvardi Therapeutics, Inc. DEF 14A 2026TVRD DEF 14A 2026: proxy statement for fiscal 2026
- Tvardi Therapeutics, Inc. DEF 14A 2025TVRD DEF 14A 2025: proxy statement for fiscal 2025
- Tvardi Therapeutics, Inc. DEF 14A 2024TVRD DEF 14A 2024: proxy statement for fiscal 2024
- Tvardi Therapeutics, Inc. DEF 14A 2023TVRD DEF 14A 2023: proxy statement for fiscal 2023
- Tvardi Therapeutics, Inc. DEF 14A 2022TVRD DEF 14A 2022: proxy statement for fiscal 2022
- Tvardi Therapeutics, Inc. Form 4 2026TVRD Form 4 2026: insider trading filing for fiscal 2026
- Tvardi Therapeutics, Inc. Form 4 2025TVRD Form 4 2025: insider trading filing for fiscal 2025
- Tvardi Therapeutics, Inc. Form 4 2024TVRD Form 4 2024: insider trading filing for fiscal 2024
- Tvardi Therapeutics, Inc. Form 4 2023TVRD Form 4 2023: insider trading filing for fiscal 2023
- Tvardi Therapeutics, Inc. Form 4 2022TVRD Form 4 2022: insider trading filing for fiscal 2022
- Tvardi Therapeutics, Inc. S-1 2026TVRD S-1 2026: registration statement for fiscal 2026
- Tvardi Therapeutics, Inc. S-1 2025TVRD S-1 2025: registration statement for fiscal 2025
- Tvardi Therapeutics, Inc. S-1 2024TVRD S-1 2024: registration statement for fiscal 2024
- Tvardi Therapeutics, Inc. S-1 2023TVRD S-1 2023: registration statement for fiscal 2023
- Tvardi Therapeutics, Inc. S-1 2022TVRD S-1 2022: registration statement for fiscal 2022
- Tvardi Therapeutics, Inc. 13F 2026TVRD 13F 2026: institutional holdings for fiscal 2026
- Tvardi Therapeutics, Inc. 13F 2025TVRD 13F 2025: institutional holdings for fiscal 2025
- Tvardi Therapeutics, Inc. 13F 2024TVRD 13F 2024: institutional holdings for fiscal 2024
- Tvardi Therapeutics, Inc. 13F 2023TVRD 13F 2023: institutional holdings for fiscal 2023
- Tvardi Therapeutics, Inc. 13F 2022TVRD 13F 2022: institutional holdings for fiscal 2022
More companies